BDX

Becton Dickinson & Company

Stock NYSE – Stock Market Prices, News & Analysis

Becton Dickinson & Company is a global medical technology company specializing in the manufacturing of medical devices, diagnostic products, and reagents.

$ 154.51
1.17 %

Becton Dickinson & Company

$ 154.51
1.17 %
BDX

Becton Dickinson & Company is a global medical technology company specializing in the manufacturing of medical devices, diagnostic products, and reagents.

Price history of Becton Dickinson & Company
Price history of Becton Dickinson & Company

Performance & Momentum

6 Months 5.02 %
1 Year 10.11 %
3 Years 14.86 %
5 Years 8.27 %

Strategic Analysis

Becton Dickinson & Company • 2026

Becton Dickinson & Company positions itself as a leading player in medical , focused on medical devices and diagnostic products. Its model is based on constant innovation to meet the growing needs of the global healthcare sector, with notable geographic and product diversification.

Strengths
  • Wide range of innovative medical devices and diagnostic solutions
  • Strong global presence with an extensive distribution network
  • Competitive advantages related to the quality and reliability of its products
Weaknesses
  • Recent stock performance characterized by a stable downward trend over several years
  • Sensitivity to complex regulations and margin pressures in the sector
Momentum

The stock's momentum has recently shown positive signs, supported by rising valuations and favorable analyst recommendations. This momentum suggests a possible recovery and improvement in market perception, warranting close monitoring to validate a sustainable trend reversal.

Analysis performed 1 month ago

Similar stocks to Becton Dickinson & Company

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone